Jon Hamilton

Scientists say new drugs are on the way for patients with ALS. The latest is a two-drug combo that appears to slow the progression of the fatal nerve disease with a modest but meaningful benefit.

NPR’s Ari Shapiro and Michel Martin are joined by NPR’s science correspondent Jon Hamilton to talk about the information about the coronavirus learned since the beginning of the pandemic.

Tests for the immune response to the coronavirus are revealing thousands of people who were infected but never got severely ill. The findings suggest the virus is less deadly than it first appeared

The majority of people recover from COVID-19, but some who have been in intensive care still have a variety of health problems, both physical and cognitive, after they leave the hospital.

“Case fatality rates have been very confusing,” says Dr. Steven Lawrence, an infectious disease expert. Here’s why.

A hospital in Seattle has set up a drive-through coronavirus testing clinic in its garage. The idea is to quickly test workers who have symptoms without putting other staff or patients at risk.

Drive-through coronavirus testing has arrived in Seattle. It allows people to simply roll down the window, get a nasal swab, and head home to wait for results.

Scientists at the University of Washington’s medical school began working on a test for coronavirus back in January. Now they’re using it to fight an outbreak in their own backyard.

Black and Hispanic people often don’t volunteer for studies of Alzheimer’s disease, despite their risks for developing it. Researchers are working to make studies more inclusive, but it’s not easy.

One medical student was addicted to opioids. Another relied on them to control disabling pain. Both think their experiences will help them be better doctors when it comes to prescribing opioids.